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Abstract 
In the last decade, the range and number of people accessing trans health care has 
increased at a faster rate than previously. Globally trans health care is commonly used 
as a requirement for trans people to access legal gender recognition. In Europe, trans 
health care is often provided within centralised health systems by a limited number 
of specialist teams placed in monopoly positions. Through a qualitative study, we 
sought to understand the relationship and role these teams have with legal gender 
recognition. We conducted in-depth interviews with a team located in Central and 
Eastern Europe and consulted with local key informants working in trans health 
advocacy outside the team. After applying qualitative content analysis emerging 
themes comprised three sections: the team in context; conceptions of trans health care; 
and beyond the clinic.  
Findings indicated that the team conceived trans identities and clinical needs 
in a medical framework that correlated with the process for legal gender recognition. 
This followed a similar historical progression across Europe. As the few respected 
specialists in the country, the team influenced care regulations within the ministry and 
held a monopoly position. While reform of some regulations was seen as needed, they 
were met with challenges within the health system and field. These challenges were, 
however, found to reflect trans health care globally rather than the team itself. Our 
findings suggest comparisons could be drawn to similar positioned teams throughout 
Europe regarding decision making, power, and influence. Increased transparency and 
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Trans people encompass a wide variety of people whose gender identity does not fit 
society’s expectations in relation to the sex and gender roles they were assigned at 
birth (European Union Agency for Fundamental Rights [FRA] 2014, 14). Trans serves 
as an umbrella term for a range of historical and emerging terms such as transsexual, 
transgender, gender non-conforming, genderqueer, non-binary and gender diverse 
(unless otherwise noted, hereafter trans) (Thorne et al. 2019)2. People may identify 
within the gender binary (male/female), between or outside (Motmans et al. 2019). 
Some people require a combination of medical services such as taking hormones and 
having surgeries to change their bodies to more properly fit their gender identity and 
expression (hereafter trans health care); others may opt for no, little, or only some 
types of medical services. While some services are considered a medical necessity for 
some trans people, not all trans people require related medical care (James et al. 2016; 
Nieder et al. 2019).  
 
Provisions of trans healthcare vary throughout the world (Coleman et al. 2012). 
In the United States of America, much care is provided in community health centres. 
In Europe, specialised centres, set in a research setting, tend to provide the majority 
of care (Deutsch et al. 2015, 2). In other parts of the world, care is either limited, non-
existent or provided solely through private clinics (Wylie et al. 2016). In most countries 
around the world, unregulated and medically unsupervised services are presumed to 
take place (Mepham et al. 2014; Winter et al. 2016). 
 
Centralised specialist centres in Europe often hold a level of monopolised 
power over trans healthcare in their respective countries (e.g. Denmark, The 
Netherlands, Norway, Serbia). These clinics face challenges and criticism in meeting 
patient demands (Hartline 2019; Krumsvik 2019; Nord 2019; Open Society 
Foundations 2013; Sharpe 2017; van der Ros 2017). In recent years, the field of trans 
health, research, visibility and rights has gained momentous traction (Bockting et al. 
2016; Motmans et al. 2019; Sweileh 2018). Likewise, the number of trans people 
seeking and accessing services has been increasing at a faster rate than previously 
seen, and the recognition of a broader range of trans identities and needs has 
expanded (Arcelus et al. 2015; Bouman et al. 2016; Eyssel et al. 2017). Discourses 
 
2 Under this umbrella term we do not imply a distinction between people with an ICD-indicated 
gender-related diagnosis and those without.  
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regarding standards of care and legal reform have simultaneously followed to the 
forefront.   
 
In several countries, trans health care is used as a benchmark for individuals to 
legally change their gender and/or name on identification documents (e.g. passport or 
identification card) (Castro-Peraza et al. 2019). Commonly referred to as legal gender 
recognition, the process has implications for trans people’s ability to maintain healthy 
livelihoods, in areas such as employment, privacy and adequate health care (Winter 
et al. 2016). Typically, these benchmarks correspond to somewhere along the classic 
trans health care trajectory, starting with a mental health diagnosis and moving 
towards genital surgeries (Wylie et al. 2016). Historically and until now, countries 
have required medical interventions up to the point of sterilisation, while other 
countries lack a legal process entirely. Some European countries have started to move 
away from medical requirements by adopting a self-determination model or relying 
on a mental health diagnosis alone (Chiam et al. 2016; ILGA-Europe 2016; 
Transgender Europe [TGEU] 2019; Winter et al. 2016). In all of these cases, health care 
professionals and specialist teams have played a role through providing and 
confirming these requirements at some point.  
 
Medical requirements have come under critique for violating human rights and 
being non-inclusive, with the self-determination model being preferred (Castro-
Peraza et al. 2019). The World Professional Association for Transgender Health 
(WPATH), an interdisciplinary and professional organisation, has opposed surgical 
requirements since at least 2010. In 2015, they stated: “No particular medical, surgical, 
or mental health treatment or diagnosis is an adequate marker for anyone’s gender 
identity, so these should not be requirements for legal gender change” (Green and 
World Professional Association for Transgender Health [WPATH] 2015). In April 
2017, the European Court of Human Rights, in the case of A.P., Garçon and Nicot v. 
France, deemed the requirement of sterilisation to be a violation of the Article 8 Right 
to respect for private and family life under the European Convention on Human 
Rights (2017). Other medical benchmarks, such as a mental health diagnosis or 
examinations, were not deemed a violation (European Court of Human Rights 
[ECHR] 2017). 
 
Criticisms and changes in requirements for legal gender recognition have come 
with a combined critique of trans health care (66th World Medical Association General 
Assembly 2015; Basterrechea et al. 2016; Hammarberg 2009; Office of the United 
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Nations High Commissioner for Human Rights 2015; Open Society Foundations 
2014). Access to trans health care in and of itself can be particularly challenging and 
met with obstacles, including lack of resources, knowledge and quality services across 
Europe (FRA 2014; Winter et al. 2016; Wylie et al. 2016). Following these expansions 
and criticisms, the level of impact centralised trans health teams have on provisions 
of care and legal gender recognition is of interest. The present study aims to explore 
this relationship and the possible consequences of a centrally located monopoly team 
in Europe retrospectively. In order to do so, we have chosen a specialist trans health 
care team located within Central and Eastern Europe as a case example. 
 
The chosen specialist team’s operates in a country with a gross national income 
(GNI) between $4 126-$12 745 per capita in 2013 and an unemployment rate of around 
20%, that is particularly high among youth (above 40%) (Organisation for Economic 
Co-operation and Development [OECD]; Blinded reference 1, 2016) 3. Structured as a 
Bismarck model, the country’s health system is a centralised health system with a 
public health insurance fund (Blinded reference 2, 2014). Medical staff are considered 
to be well trained. However, the health system is underfinanced and corruption has 
been considered to be wide-spread (Blinded Reference 3, 2017). In the last decade, 
trans healthcare has been approved to be mostly paid for by the national health 
insurance (Blinded reference 4, 2012). In 2016, the country was among 23 countries in 
Europe that required sterilisation for gender recognition. In 2018, they were among 33 




Methodologic Approach and Study Design 
 
In-depth interviews were conducted with the chosen team of gender specialists in the 
country described. As the research field is sparse, we chose a qualitative study using 
in-depth interviews and content analysis in order to inductively build a framework to 
conceptualise the relationship and “systematically describe the meaning of qualitative 
data” (Cho and Lee 2014, 170; Schreier 2014). This approach allows for understanding 
 
3 References have been blinded in order to anonymise the study country. A full reference list can be 
requested from the corresponding author. 
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the experiences and the relationship from the practitioner’s point of view rather than 
from outside perceptions (Charmaz 2014). 
 
Recruitment and Sampling 
 
All known members of the team were approached for interviews as well as two people 
known to be working with trans healthcare at the community level (key informants).  
Team members were identified through their public self-identification with the field, 
referral from their colleagues or key informants. 88% of the known team participated 
in an interview and consisted of mental health and surgical care professionals. 
 
Key informants were sought as a means to achieve data triangulation and 
reflexivity with interview data. This was additionally chosen as means to verify 
possible participant bias and socially desirable answers. Key informants were selected 
due to their roles as professionals working with trans healthcare outside the 
traditional medical system (e.g. international and local trans advocacy non-
governmental organisations (NGO), community organisations, within peer-support 
groups, and researchers) as well as working with trans specific legal reform inside the 
country and abroad. This has provided a local community and patient perspective as 
a means of triangulation and reflexivity. Key informants were additionally selected 
due to previously established rapport with the researcher. Key informants 
participated in semi-structured and casual conversations (e.g. Skype, email, scheduled 




Since the specialists discussed in this study are working in a controversial and limited 
field (such as transgender health care) and are subject to high vulnerability, 
participants were anonymised. Lack of anonymity would increase the risk of being 
recognised based on their statements and accordingly receiving negative 
consequences. This has particularly high importance in an area of health care that faces 
social-political obstacles and has a limited number of professionals. In order to achieve 
anonymity, we removed the name of the country, the institution and background 
information on the political situation and specific legal regulations in this country. 
Information provided about the country context has been provided broadly. 
Reviewed Article                                       International Journal of Gender, Sexuality and Law 
329 
 
References that have the potential to identify the participants or the country have been 
blinded throughout the study as well. 
 
The purpose and design of the study were explained to each interviewee and 
informant in writing before scheduling interviews. Written and oral informed consent 
was obtained before each interview, including consent to be identified by profession 
and to be quoted. Informed consent was sought in the same manner from key 
informants.  
 
In order to respect participants’ right to privacy, confidentiality and 
anonymity, we have opted to refer to participants as a group rather than as individual 
pseudonyms or characteristics. We believe pseudonyms or other individualised 
characteristics, such as speciality, would not suitably achieve anonymity. We have 
opted for describing participants as a range of professionals as well as presented data 
without participant numbers in order to further avoid identifying data to specific 
individuals. We understand that complete anonymisation in any type of qualitative 
research is difficult and we have strived to ensure confidentiality and anonymity in 
the best way possible. 
 
Data Collection and Analysis 
 
Following background research and a literature review, a general interview guideline 
was developed in collaboration with both authors and consultation with key 
informants to ensure local and cultural context. Focused questions were developed 
for individual specialties (i.e. surgical specifics) and taken into consideration during 
interviews. Interviews covered four main themes: the history and structure of the 
team; service provision and patient range; challenges; and future developments. 
 
In-depth semi-structured interviews were conducted in English with 8 
members of the team by the first author between 20 February - 11 April 2017. Each 
interview lasted on average 57.57 minutes (9 min – 97 max, Median = 55, IQR 42 – 85, 
n = 7). Four interview partners were interviewed in groups of two, based on 
availability and their working relationship, while the rest were interviewed 
individually. This variation in interview structure thus impacted both the 
standardisation of interviews as well as the amount and type of information shared 
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by each interview partner. Data saturation was considered to be reached when 80% of 
known members of the team were interviewed. Discussions with key informants took 
place on-line and in person in the country prior and during the interview period. 
 
Using MAXQDA Plus 12.3 (VERBI GmbH Berlin 2017), an inductive content 
analysis was applied in order for key themes and concepts to emerge (Elo and Kyngas 
2008; Mayring 2010). Each interview was transcribed verbatim and then read once for 
accuracy and once for content. Transcripts were organically coded by assigning a 
descriptive term for each relevant passage of text. Summaries of each code were then 
read, compared for consistency and recoded for any mistakes or duplicates. This 
process was duplicated in a focused manner for additional continuity and reflection, 
resulting in a coding scheme. Codes were reviewed by a fellow student and discussed 
for bias and reflexivity. Memos were additionally attached to blocks of text with either 
key findings, need for clarification, or direct connection to other participants. Key 
informant data was utilised as cross-reference data for triangulation, participant bias 
and a level of community perspective, rather than explicitly as primary source data. 
Codes were grouped into categories and reflected between researchers and the fellow 
student. Categories were ultimately organised into overarching themes and 
discussed. See figure 1. 
 






As a result of applying qualitative content analysis, a descriptive section was 
identified followed by four main themes: provisions of care; ensuring and improving 
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lives; interests of the team; and structural restraints and barriers. Main themes were 
disaggregated into two main sections (Table 1).  
 
Table 1: Summary of Results 
Section Emerging Themes 
I:  The Team in Context 
II: Conceptions of Trans Health 
care 
Provisions of Care 
Ensuring and Improving Lives 
III: Beyond the Clinic 
 
Interests of the team 
Structural Restraints and Barriers  
 
Section I: The Team and Services in Context 
 
Trans people living in the capital received a referral from a general practitioner or 
another psychiatrist. Patients outside the capital were referred by a psychiatrist and 
then approved by a commission prior to referral to the team. Care followed a 3-stage 
linear path which begun with a psychiatric and psychological assessment lasting a 
minimum of 1 year. Following the assessment phase, a minimum 1 year of hormone 
therapy and recommendation letters from approved psychiatrists, the patient was 
able to undergo gender affirmation surgery. Following the surgery, transition was 
considered complete and would allow for the possibility to legally change one’s 
gender marker. 
 
Section II: Conceptions of Trans Health care 
 
Provisions of Care 
 
The team perceived and provided care in a way that was informed by their past 
clinical experiences. They had a goal to make a consistent and correct diagnosis and 
promote healthy social functioning. This was seen as a way to prevent trans people 
from making, what they considered, could be a life altering mistake - thus putting the 
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team a decision-making role. The team recognised their primary work with 
individuals they described as transsexual2 with a goal to undergo genital surgeries, 
complete their transition and ultimately allow for legal gender recognition. Key 
informants expressed that they knew of a number of people who felt they had to alter 
their narrative to clearly express a desire for lower body surgeries in order to receive 
some level of care, such as hormones. 
“We have to do two things which are a great responsibility, identify 
transsexualism [and make a diagnosis], if we make a mistake and a person is 
only transgender and not transsexual then the operation would make him 
miserable. The other responsibility is his life afterwards, this real-life test, this 
assessment period is for all of us to see whether after the surgery he would be 
miserable because he would have lost his family support, supportive friends, 
had nothing to eat because he had no money, no job so what use could it be?” 
 
“There are some, probably some people [who express not wanting surgery] but 
we usually deal with patients that want to pass all three [stages], at the form of 
extreme transsexualism, severe. I mean they are only referring to us or coming 
to us if they think about an operation.” 
 
Assessments were used as a means to be confident that the person’s identity is what 
the patient thinks and treatment is necessary. However, practitioners recognised that 
evaluations and tests were unable to rigorously diagnose a patient and depended on 
clinical experience. 
“Usually I refer them to a psychologist to do some testing, not because these 
psychological tests will show that they are transsexual because they don’t, until 
now there is no such refined test that can show us, it’s just clinical experience.” 
 
Doctors had particular concern that patients could either have compounding mental 
health issues or regret undergoing genital surgery. The team recalled cases of reversal 
or retransitions surgeries, such as phalloplasty following a vaginoplasty. This type of 
case provided justification for time bound assessments. At the same time, it was found 
that the team had a slight variation in their strictness of specific requirements. Key 
 
2 Participants have made a distinction between transsexualism and transgender in line with the 
historical progression of medical classifications. Transsexualism is distinguished from transgender by 
people who wish to undergo lower-body affirmative surgeries, whereas transgender more generally 
refers to people who identify as a different gender than assigned at birth (see discussion). 
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informants referred people to members who they felt had ‘updated’ and more flexible 
practices. Some practitioners recognised that patient identities were changing and that 
they needed additional experience, reflecting on their confidence to diagnose patients. 
This demonstrated an understanding of their limitations as a team and room for 
growth. 
“Most of our patients are what we called in the past true transsexualism, 
meaning with an early onset of gender dysphoria. We still don’t have that much 
patients of non-binary, genderqueer and so on. They are just starting to come in 
this previous year or so. Which is quite a different picture … I suppose that we 
have to be prepared and educated for this because we don’t have any 
experience.”  
 
Ensuring and Improving lives 
 
The team further emphasised the difficulty of transitioning within the context which 
was then reflected in some of their practices and intentions. The important role of the 
family culturally and economically influenced patients, both adolescents and adults, 
to be open about their identities to their families before transition and led to the team 
partly questioning patients’ autonomy in doing so. Depending on these 
circumstances, outing oneself could be a requirement to continue care. The team also 
recognised an informal type of gender recognition documentation used that would 
later translate into the legal framework. These two examples show reflection upon 
their influence. 
“Many of them come to us and their parents still don’t know about the problem 
they have. So, the first thing is go back and tell your family, if they are not already 
independent or they live away from the family, I mean how can you go operate 
yourself and then visit your family and say “I’m a female now” or “I’m a male 
now”." 
 
“We have one specific [example] in the social context where they start with the 
hormone treatment. I put on some small paper, some report, that they are 
diagnosed with transsexualism and they are on endocrinology treatment. I say 
to them to put that in their wallet and if they go out to some party and suddenly 
the police make some control or otherwise. They always try to communicate that 
stuff with the policeman but if they have problems I said “You put this out and 
show them” and it goes well!” 




Key informants confirmed that this informal type of legal gender recognition was 
useful and accepted as a way to have documentation if legal gender recognition was 
not available legally.  
 
Section III: Beyond the Clinic 
 
Interests of the team 
 
While the team’s reflections on society influenced some of their informal clinical 
practices, the team had also defined and influenced regulations within the Ministry of 
Health. Following the adoption of a new health insurance law, regulations 
determining service provision were set forth by the ministry. According to the team, 
the regulations were developed by a newly established board within the ministry 
which consisted of a majority of the team. This concurrently approved the team as the 
sole providers of trans health care in the public scheme by the Ministry of Health. 
“We made some practical guidelines within the Ministry of Health how to 
explore and how to treat those patients from the very beginning till the end. Our 
clinic and [names omitted] are the [omitted] clinics that are certified from the 
Ministry of Health to do the exploration and proposal for treatment, so that’s the 
fact that all people from all [over our country] are coming here and [omitted].” 
 
Key informants noted that only permitting the psychiatrists in the team to provide an 
initial diagnosis within the national health insurance functionally maintained a 
monopoly. This further meant that they were the only psychiatrists permitted to write 
surgery recommendation letters for similarly approved surgical team members. Key 
informants expressed additional concern that this made it difficult for patients to feel 
in-control of their transition options because the limited team was the only approved 
individuals to provide care. They also expressed concern that this affected some 
patients feeling that participating in research by the team was not in-fact voluntary. 
This was further influenced by long waiting periods and team members also working 
in private practice. Both the team and the key informants recognised that there are 
other surgeon(s) working privately outside the team; however, they had lost 
professional contact and believed they were primarily attending to patients from 
abroad. 




Almost every member recognised that they were working in both public and 
private practice. Key informants expressed additional concern that patients can feel 
pressured to go to private practice in order to receive more flexible and timely care. 
This was similarly recognised by at least one practitioner and influenced their 
response and understanding of their role. Others recognised the dual role in a way 
that encouraged them to work in public and private care.  
“I was part of a team involved in both places, professional team and in health 
insurance, we were supposed to see whether transsexual clients have all 
sufficient conditions to go for surgical treatment. So I thought it was a conflict of 
interest if I was in private practice, I mean there is no rule but I know my clients 
might think that I am there so they have to go to my private practice in order to 
get a signature from me, so now I am completely in private practice.” 
 
“[Colleague] was insisting in doing the surgeries in public hospital for these 
people because if you look at economical way for me it is much better to work in 
private hospital where I will get paid for the surgery. My interest, is not to work 
without specific salaries as so I have private patient who is paying, I am getting 
a percentage.” 
 
Despite their role in private or public practice, their role within decision making and 
the ministry gave them a respectable level of medical authority and authenticity for 
disseminating socially acceptable knowledge. 
“The other thing that is pretty important is that the ministry of health have 
accepted and certified us, it gives the opportunity that we can speak about these 
phenomena … for our country it’s extremely important if someone will listen to 
you and accept what you are talking about.” 
 
This approval provided the team with a level of validation and showed an 
understanding of the importance of their role.  
 
Structural Restraints and Barriers 
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Structural restraints and barriers had a potential impact on the team’s ability to further 
change regulations within the ministry. There was a need to fight for prioritisation of 
the issue within a strained system and against other professionals. However, despite 
challenges that were unique to the context, practitioners recognised that the field is 
challenging and widely misunderstood globally, highlighting that this was not unique 
to their country and therefore made their role increasingly important. 
“Well we always have challenges because this is a quite edgy team and 
controversial team and controversial country where we live. When you have all 
the paradoxes here, you have storming’s and fightings and everything … We all 
have the controversies why should we do some financial to this thing, so you 
have to explain that again and again, why it’s useful, why it’s good you know … 
General practitioners of psychiatry [within our country], do not know anything 
about this and how to explore thoughts.” 
 
“First our colleagues not only in [our country] but I mean all over the world 
really don't understand the small differences between the terms [gender 
dysphoria, gender identity disorder, homosexual, transsexualism] so this is why 
we need to make [ourselves as a team] more approachable to the community.” 
 
The team and key informants recognised that providing trans healthcare had 
improved since there had been insurance coverage of services. However, they 
mentioned a number of persisting challenges, predominantly due to the structure of 
the health system and regulations set forth. Resources were a key challenge in terms 
of services that were covered, as well as a need for more individuals approved to 
provide care, highlighting their strain as a monopoly. 
“As the number of patients are growing we will have to do something in the 
future but we have to cover a lot of technicalities relating to other parts of work 
that we do. … To have more time and more persons involved would be great, 
that is most important, the time we need and the persons involved that’s the 
main thing and it’s a challenge how to accomplish this.” 
 
The team identified that as trans healthcare has evolved the regulations have become 
limiting and may have been not solely determined by the team. Some participants 
identified how the lack of formal legal gender recognition policies along with informal 
sterilisation requirements limited flexibility in options for their patients and also 
violated their rights. They further stated that changing this law could be beneficial to 
Reviewed Article                                       International Journal of Gender, Sexuality and Law 
337 
 
patients and the transition process but needed to be strategic and timely to be 
successful. 
“You also have certain percentage of patients that stop after doing the top 
surgery, they don’t wish to have genital surgery and it is not something that they 
have to do, but according to the law in [our country] they won’t be able to change 
their legal documents. For example, they can change the name to take a unisex 
name but they would stay female because they still have female reproductive 
organs… First it has to be legally changed, first because now they cannot get the 
new documents without completing all steps, like psychiatrist, endocrinologist 
and complete surgery, not to have anymore any signs of the previous gender. 
So, if that changed then the patient has more possibilities to choose … The law 
needs to give the possibility to for example not remove the uterus and the ovaries 
if they want because if they want to preserve their fertility even according to all 
laws everybody has the right to be parents.” 
 
“This [assessment time frame] is regulated by the ministry to be one year, that is 
the period of time … The challenge is that we have an urge for mastectomy in 
patients before [hormone] therapy, they have that need, but we don’t have the 
guidelines, the ministry didn’t allow that for them at this moment…. We have to 
work on trying to change that in future, but we have to do slowly step by step if 
we want to be accepted. For example, there are some this these activist’s 
organisations they want to fast and now alarming and screaming for that but it’s 
not smart to do it like this.” 
 
Key informants expressed that the team supported a new bill on legal gender 
recognition drafted by NGOs but also felt they were not transparent enough about 
their role within making regulations and policy recommendations. Both the team and 
the key informants expressed that they felt they did not always understand each other, 
especially regarding priorities. They did however cooperate and have a positive 
working relationship. 
“Our cooperation with NGO’s in some things we do, we cannot find agreement, 
and I feel we do not maybe understand each other. This depathologising trend 
is something … it has to be a kind of something if you need treatment for it you 
know.” 
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“A couple of months ago one of the leaders of one of the LGBT associations from 
[our country] … they were trying to remove the word disorder or remove 
actually transsexualism from the ICD at all, like to remove it because it is not 
considered as a disease, it is a state but not a disease … so I mean okay if you 
remove all of that from everywhere so it is not a disease, it is not a disorder, it’s 
not anything. What are we treating then?” 
 
This discrepancy can illustrate how NGO’s and people outside the clinical field 
influence their opinions but also reflects their role within trans health care and the 




This study explored the relationship between a monopolised trans health service in a 
centralised health system and their impact on provisions of care and legal gender 
recognition. Our findings suggest a correlation between how the team conceived trans 
identities and clinical needs with the process for recognition. The team stated that as 
the respected specialist in the country they had an influential role, particularly in 
creating recommendations and regulations. Reform of some regulations was seen as 
needed but met with challenges and kept within a medical context. 
 
While some patients began to express a desire to not receive surgery, the team 
saw their work primarily with patients they described as transsexual. Participants 
made a distinction between ‘transsexuals’ who wish for a number of surgeries and 
‘transgender’ people that may not have a strong or initial desire for surgeries. This 
distinction informed the prescribed transition path and how care was provided by 
some of the team and could limit access to care and legal recognition for people who 
do not identify as transsexual (Motmans et al. 2019; Thorne et al. 2019; van der Ros 
2017). This understanding of gender identity can be reflected in the changes in the 
International Classification of Diseases (ICD) from ‘Gender identity disorders’ (F64) 
and ‘transsexualism’ (F64.0) in Chapter V: Mental and behavioural disorders in the ICD-
10 to ‘Gender Incongruence of adolescence or adulthood’ in Chapter 17 of Conditions 
related to Sexual Health in the ICD-11 (World Health Organization 2016; 2018). 
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The team recognised trans people as needing medical care to treat and cure a 
diagnosis through long-lasting medical changes; otherwise, they did not understand 
the purpose of providing clinical care. Thus, putting gender identity into a medical 
framework excluded people who do not require medical care. This was highlighted 
through the understanding of their role and responsibility in making a correct 
diagnosis. However, they stated that there is no test to diagnose being trans and 
therefore it requires first-hand clinical knowledge and experience. This finding was 
emphasised through the practice and regulation of conducting an assessment for a 
minimum of one year before beginning hormone treatment. This practice has been 
criticised for delaying care as hormones are a common motivator and entry point for 
trans people to seek care (Deutsch 2016, 201).  
 
Although seen as assisting patients in navigating transition in a challenging 
context, benchmarks and encouragement of coming-out has been noted as 
paternalistic and a way to question patient autonomy. These practices are known to 
influence a patient-provider dynamic in which patient narratives are “likely to lead to 
very schematic presentation of people’s personalities” (Nieder and Richter-Appelt 
2011, 232). This was a matter of concern for key informants regarding patient decision 
making and the level of gatekeeping power the team holds. As Fraser (2015 abstract) 
stated, trans health care has evolved from “a binary to a spectrum approach of gender 
and the corresponding change from a sex-change and one-size-fits-all model of 
medical treatment to the currently broader and individualised approaches to health 
care”. Thus, this understanding of confirming trans identities through linear medical-
related benchmarks can be viewed as outdated. 
 
Participants recognised changes in the field and the need for more flexibility in 
the regulations, such as mastectomy before hormones or an easing of which surgical 
procedures allow for legal gender recognition. However, these provisions of care 
appeared to directly correlate with the regulations that guided the team. It became 
evident that a number of the team were the individuals approved by the Ministry of 
Health to provide care, made up the board within the ministry, and had an initial 
influence on the regulations. The finding that one participant felt a conflict of interest 
as a board member developing regulations while also working in public practice 
pointed to the extent of self-regulation and justification. Interestingly, the self-
influenced regulations of medical-related benchmarks additionally correlated to the 
same benchmarks used for approving legal gender recognition.  
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Key informants showed concern that this dual approval essentially made the 
team a monopoly. This was illuminated through their sole approval to provide care 
including writing recommendation letters for surgery. Their relationship with NGOs 
expressed a power relationship and varying opinions in regards to timing, priorities 
and the necessity of changes. 
 
The use of an informal gender recognition method through providing 
documentation once hormones were begun showed that the team recognised their 
influence and the immediate ways that they can act. This type of documentation could 
be correlated with changes across Europe allowing for legal gender without or before 
surgery (Chiam et al. 2016; ILGA-Europe 2016; TGEU 2019; Winter et al. 2016). 
 
This finding of monopoly and power drew attention when a consortium of 
NGOs released a press statement prior to the amendment of the law kindly asking for 
a meeting with the relevant ministries and the board. They cited concern that the 
process had been secretive and non-inclusive as well as arguing that proposed gender 
recognition required surgery and sterilisation, legally mandating that team members 
must provide the services (Blinded reference 5, 2018). Thus, it reinforced the 
monopoly and restricted care to the team’s location. 
 
The country has since removed sterilisation and surgery as the sole benchmark 
for legal gender recognition – an improvement in accordance with the ruling in A.P., 
Garçon and Nicot v. France and human rights (2017). However, as of 2018, they were 
among 33 countries in Europe that require a health-related benchmark of a mental 
health diagnosis which was deemed an inadequate marker of gender identity by 
WPATH in 2015 (Green and WPATH 2015; TGEU 2019). According to one report from 
a consortium of NGOs published after the research, care is more accessible to a wider 
range of patients and identities in 2018 (Blinded reference 6, 2018). 
 
This study was unable to conclude the direct role the team had in formulating 
legal gender recognition laws; however, their position and historical influence 
suggests that some involvement is likely. We believe that interviews with the team 
coupled with perspectives from key informants have provided a perspective that is 
unique in understanding how trans health specialist and care provisions can correlate 
with legal gender recognition processes.  





As the field of trans health care has continued to rapidly evolve, the study would 
benefit from follow-up interviews. Inclusion of lawmakers and members of the 
government would have provided an additional perspective on the influence of the 
team. Direct inclusion of patients would have been beneficial to gain first-hand 
accounts of receiving care and applying for legal gender recognition. Inclusion of key 
informants was, however, used as a data proxy. Interviews varied in the number of 
people and the interview guide was adapted to each speciality, therefore interviews 
became non-standardised affecting the amount and type of data from each interview. 
Similarly, consultations with key informants took place offline and online are were 
non-standardised, limiting the data collection. Such means of data collection, sample 
selection and qualitative study design, therefore, can bring into question the direct 




Our findings suggest a comparison to other European countries in which trans health 
care is often directly connected to legal gender recognition (TGEU et al. 2017). The 
team provided care and conceived trans identities in a medical framework similar to 
the historical progression of trans health care and legal gender recognition found 
across Europe (Wylie et al. 2016). The concern that doctors not only in their country 
but all over the world do not understand trans health care illustrates that these 
challenges are not unique. All participants expressed a need for more resources that 
were beyond the team’s control (e.g. time, people and money), which is emblematic 
of obstacles and access to trans health care found across Europe (FRA 2014). Other 
trans health care teams positioned as monopolies within the health care system are 
also noted to face similar criticism and challenges (Nord 2019; Sharpe 2017). The single 
team in Norway for example similarly, “extends its monopoly in three directions: with 
regards to patients, other doctors, and the public authorities” (van der Ros 2017).  
 
Across Europe and globally trans health care continues to evolve along-side 
legal gender recognition to follow patient-led and self-determination models, 
separating legal gender recognition from medical benchmarks. Despite this 
separation, trans health care providers will continue to play a vital role for many trans 
people who need related health care. With this separation, changing models of care, 
Reviewed Article                                       International Journal of Gender, Sexuality and Law 
342 
 
continued increase in people seeking care and broader recognition of trans identities, 
further research into the impact trans health care specialist have on legal processes 
will be needed. The process for appropriate clinical reform and human rights 
implementation will require increased transparency and cooperation between local 
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volunteering their limited time as well as key informants for volunteering their time 
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